Related by context. All words. (Click for frequent words.) 73 Peripheral Artery Disease 72 Critical Limb Ischemia 72 complement inhibitor eculizumab 71 Cardiotoxicity 70 Ischemic 70 familial amyloidotic polyneuropathy FAP 70 Esophageal 69 Bronchiectasis 69 SHPT 69 ST Elevation Myocardial 69 Hyperlipidemia 69 Pulmonary Arterial Hypertension 69 Non Alcoholic Steatohepatitis 69 occlusive disease 69 Benign Prostatic Hyperplasia BPH 68 CYT# potent vascular disrupting 68 Overactive Bladder 68 Pelvic Organ Prolapse 68 CT Angiography 68 Peripheral Arterial 68 functional mitral regurgitation 68 atypical Hemolytic Uremic Syndrome 68 Metastatic Prostate Cancer 68 STRIDE PD 68 PAOD 68 chronic thromboembolic pulmonary 68 hyperphenylalaninemia HPA due 68 Natalizumab 68 ATTR 67 Myelodysplastic Syndrome MDS 67 Prospective Randomized 67 Benign Prostatic Hyperplasia 67 Diabetic Neuropathy 67 Hormone Refractory Prostate Cancer 67 Hypertrophic 67 Thrombus 67 Nebulized 67 Catheter Ablation 67 Infarct 67 Chronic Sinusitis 67 Clinical Outcome 67 Phase Ib Clinical Trial 67 Systemic Sclerosis 67 intermittent claudication 67 Castration Resistant Prostate Cancer 67 pulmonary hypertension PH 67 Renal Cell Carcinoma 67 Hepatocellular Carcinoma 67 benign prostatic hypertrophy BPH 67 ADPKD 67 NATRECOR ® 67 Non Alcoholic Fatty 67 inflammatory acne 67 Neovascular Age Related Macular 67 Decitabine 67 dual endothelin receptor antagonist 67 metastatic neuroendocrine tumors 67 Acute Ischemic Stroke 67 Acute Decompensated Heart Failure 67 Autologous Stem Cell Transplantation 67 Safinamide 67 Radioimmunotherapy 67 diarrhea predominant irritable 67 Chronic HCV 66 Hypotension 66 Iron Overload 66 Malignant Melanoma 66 overactive bladder syndrome 66 Severe Asthma 66 Myelodysplastic Syndrome 66 treat benign prostatic 66 occlusion CRVO 66 Hepatic Encephalopathy 66 vWD 66 Phase 2b Trial 66 Subarachnoid hemorrhage 66 Prolongs Survival 66 mixed hyperlipidemia 66 claudication 66 IV NSCLC 66 stage IIIB 66 invasive candidiasis 66 Oral Fingolimod 66 Relapsing Remitting Multiple Sclerosis 66 Enzyme Replacement Therapy 66 metastatic malignant 66 CIPN 66 Myelofibrosis 66 Refractory Angina 66 PEGylated interferon beta 1a 66 Left Ventricular 66 Diabetic Foot Ulcer 66 Pooled Analysis 66 Coronary Artery Bypass Graft 66 Occlusive Disease 66 post thrombotic syndrome 66 artery stenosis 66 Hemolysis 66 Venous thromboembolism 66 Ranolazine 66 Randomized Study 66 chronic myocardial ischemia 66 Ischemia 66 neovascular 66 esophageal candidiasis 66 Atrial Flutter 66 Fibrosis 66 Systemic Lupus Erythematosus SLE 66 Clinical Trial Results 66 Soft Tissue Sarcoma 66 Meets Primary Endpoint 65 Mitral Regurgitation 65 Lupus nephritis 65 Carcinomas 65 Non inferiority 65 uricase 65 Atypical Hemolytic Uremic Syndrome 65 ankylosing spondylitis AS 65 Acute Coronary Syndromes 65 Patients Undergoing 65 prospective multicenter study 65 Diabetic Retinopathy 65 INCB# [003] 65 Surgical Treatment 65 gastroduodenal 65 Rheumatoid 65 stable angina pectoris 65 Tyrosine Kinase Inhibitors 65 Acute Myocardial Infarction AMI 65 Cutaneous T 65 vertebral compression fractures 65 relapsed MM 65 recurrent glioblastoma multiforme 65 Neoplasms 65 gastrointestinal stromal tumors GIST 65 Leukemias 65 Follicular Lymphoma 65 Adult Stem Cell Therapy 65 Dupuytren Contracture 65 transcranial Doppler ultrasound 65 Unresectable 65 Aneurysm Repair 65 Coronary Arteries 65 Metastatic Melanoma 65 Degarelix 65 terlipressin 65 postoperative atrial fibrillation 65 Adjunctive 65 Allogeneic 65 Naive Patients 65 relapsing multiple sclerosis 65 osteoporotic vertebral compression fractures 65 Toxicities 65 Phase 2b Clinical Trial 65 Peripheral arterial disease 65 Coronary Artery 65 invasive aspergillosis 65 Mucositis 65 hepatorenal syndrome 65 Radiofrequency Ablation 65 MR Angiography 65 Thrombotic 65 Squamous Cell Carcinoma 65 Aortic stenosis 65 Placebo Controlled Study 65 NAVISTAR R 65 Secondary Hyperparathyroidism 65 Catheter Associated 65 Chronic Heart Failure 65 leiomyomas 65 ST Segment Elevation 65 Knee Osteoarthritis 65 Vertebral Compression Fractures 65 Patients Treated With 65 Relapsing Multiple Sclerosis 65 Study Evaluating 65 Hepatocellular Carcinoma HCC 65 Chronic Myeloid Leukemia 65 Renal Cancer 65 Rheumatoid Arthritis RA 65 recurrent glioma 65 Sezary syndrome 65 leukemia AML 65 transplantation HCT 65 Post Operative 65 Neovascular AMD 65 Chronic Bronchitis 65 CTEPH 65 Pivotal Trial 65 mycosis fungoides 65 CIMZIA ™ 65 Renal Cell Carcinoma RCC 65 phase IIb trial 65 Pemetrexed 65 Oral Mucositis 65 Localized Prostate Cancer 65 Epidermal Growth Factor Receptor 65 II Clinical Trial 65 FDG PET imaging 65 malignant ascites 65 ACE Inhibitors 65 AA Amyloidosis 65 Immunosuppression 65 Non Invasive Treatment 65 HeFH 65 symptomatic benign prostatic 65 Kepivance 65 Progenitor Cells 65 Fracture Risk 65 secondary hyperparathyroidism 65 bacterial prostatitis 65 Unfractionated Heparin 65 Diabetic Macular Edema 65 Host Disease GvHD 65 Pivotal Clinical Trial 65 Intracranial 65 Juvenile Idiopathic Arthritis 64 Heart Failure Patients 64 Treating Chronic 64 CTAP# Capsules 64 myocardial infarction ventricular fibrillation 64 Diamondback #deg 64 Brain Metastases 64 Embolic Protection Device 64 Infarction 64 toenail onychomycosis 64 PSMA ADC 64 systemic fungal infections 64 Claudication 64 Cystectomy 64 hypervascular tumors 64 Antiviral Therapy 64 endoluminal stent graft 64 superficial femoral 64 budesonide foam 64 Percutaneous Tibial Nerve Stimulation 64 Regenerative Cells 64 Diabetic Patients 64 Allergic Rhinitis 64 Phase III Clinical Trial 64 Metastatic Renal Cell Carcinoma 64 Lupus Nephritis 64 Thrombocytopenia 64 chronic opioid 64 Pivotal Study 64 Chronic lymphocytic leukemia 64 myelofibrosis polycythemia vera 64 allogeneic hematopoietic stem cell 64 Eculizumab 64 unfractionated heparin UFH 64 hyperplasia BPH 64 Phase 2a Clinical Trial 64 cartilage lesions 64 urolithiasis 64 Advanced Renal Cell 64 A1PI 64 aortic root replacement 64 PsA 64 Stomatitis 64 Vascugel 64 Advanced Melanoma 64 thoracic aortic aneurysms 64 reflux esophagitis 64 Hemorrhagic Stroke 64 Myocardial Infarction 64 Tumor Response 64 transthyretin TTR mediated amyloidosis 64 Complicated Skin 64 inhibitor RG# 64 REMINDER ORLive Presents 64 Dupuytren Disease 64 critical limb ischemia 64 NAGS deficiency 64 Adjuvant Chemotherapy 64 Liver Failure 64 Central Retinal Vein 64 Keratitis 64 Microalbuminuria 64 Thromboembolic 64 Polyneuropathy 64 Randomized Evaluation 64 Rheumatoid Arthritis Patients 64 proliferative retinopathy 64 J Am Soc 64 Thrombolysis 64 Embolization 64 neurological manifestations 64 urothelial carcinoma 64 Randomized Clinical Trial 64 Parathyroid Hormone 64 liposomal amphotericin B 64 osteoporotic vertebral fractures 64 Acute Bacterial Sinusitis ABS 64 venous stasis ulcers 64 B Cell Lymphoma 64 riociguat 64 Ischemic Stroke 64 Abciximab 64 Thiazolidinediones 64 Radiofrequency ablation 64 Diabetic Macular Edema DME 64 Antibody Therapy 64 beta 1a 64 Ventricular Tachycardia 64 XIENCE V PROMUS Stent 64 Serious Infections 64 hematologic disorders 64 atherogenic dyslipidemia 64 Hormone Receptor Positive 64 paroxysmal nocturnal hemoglobinuria 64 Carotid 64 Initiates Clinical Trial 64 HBeAg negative 64 Severe Primary IGFD 64 Fungal Infections 64 Glatiramer Acetate 64 Predict Risk 64 Dacogen decitabine 64 Hypertrophy 64 Sapacitabine 64 colorectal carcinoma 64 anterior uveitis 64 CentriMag 64 See CLINICAL PHARMACOLOGY 64 Inflammatory Diseases 64 Ultrasonography 64 purpura ITP 64 Chronic Prostatitis 64 Surgical Procedures 64 Trandolapril 64 Dual Antiplatelet Therapy 64 Lymphoid 64 Minimally Invasive Procedure 64 Gastrointestinal Stromal Tumors 64 PICSO ® 64 aminotransferases 64 gastric adenocarcinoma 64 Thromboembolism 64 Stent Thrombosis 64 Tiotropium 64 Peripheral Arterial Disease 64 Corneal Transplant 64 Novel Oral 64 Renal Artery 64 Diabetic Foot Ulcers 64 bullous 64 efalizumab 64 Severe Sepsis 64 photocoagulation 64 pathologic myopia 64 Retreatment 64 Alkaline Phosphatase 64 Navelbine ® 64 diabetes dyslipidemia 64 Critical limb ischemia 64 Patients Receiving 64 Intracranial Aneurysms 64 Anticoagulants 64 Elderly Patients 64 peripheral arterial occlusive disease 64 nephrotoxicity 63 Hepatotoxicity 63 cytopenias 63 Septic Shock 63 GOUT 63 allogeneic bone marrow 63 Hematologic 63 osteoporotic compression fractures 63 Clinical Relevance 63 systolic hypertension 63 choroidal neovascularization 63 lupus erythematosus 63 biliary tract cancer 63 rotigotine transdermal patch 63 Trigeminal Neuralgia 63 Uric Acid 63 Neovascular 63 endoscopic resection 63 Neoadjuvant Chemotherapy 63 SilverHawk Plaque Excision System 63 Meningiomas 63 AMPLATZER R 63 arthritis PsA 63 Chronic Myelogenous Leukemia CML 63 Prospective Multicenter 63 Cilostazol 63 liver resection 63 Hyperparathyroidism 63 First Patient Enrolled 63 Ejection Fraction 63 diabetic peripheral neuropathy DPN 63 Nilotinib 63 Stent Restenosis 63 intracranial hemorrhage ICH 63 Degenerative Disc Disease 63 macroalbuminuria 63 Paroxysmal Nocturnal Hemoglobinuria PNH 63 diabetes mellitus DM 63 ALA PDT 63 Glypromate 63 adult chronic ITP 63 HuMax EGFr 63 kidney urologic 63 Oesophageal 63 thromboembolism 63 Systemic lupus erythematosus SLE 63 Metastases 63 Acute Coronary Syndromes ACS 63 Adenomas 63 Aortic Stenosis 63 serum phosphate 63 Solid Tumors 63 Valopicitabine 63 pancreatic adenocarcinoma 63 Onychomycosis 63 Cell Lymphoma 63 Myocardial Ischemia 63 intravesical infusion therapy 63 Renal Failure 63 intravesical therapy 63 Intravesical 63 Dose Ranging Study 63 atrophic gastritis 63 J Shoulder Elbow 63 Liver Metastases 63 Electrical Stimulation 63 somatostatin analog 63 Phase IIb Clinical Trial 63 INSPIRE Trial Phase III 63 dyslipidaemia 63 Angioedema 63 hypervolemic hyponatremia 63 Vertebral Fractures 63 p# biomarker 63 primary hyperparathyroidism 63 Bazedoxifene 63 malignant pleural mesothelioma 63 vapreotide acetate 63 Esophagitis 63 Ischaemic 63 Neutropenia 63 Drug Prevents 63 Acute Renal Failure 63 Anti VEGF 63 percutaneous vertebroplasty 63 Intravascular 63 Subtypes 63 bypass grafting 63 recurrent NSCLC 63 Mild Cognitive Impairment 63 TLIF 63 Controlled Trial 63 FDA Approvals 63 Tyrosine Kinase Inhibitor 63 Acute Myocardial Infarction 63 Relapsed Refractory 63 atherothrombotic disease 63 Extracorporeal Shock Wave 63 Endologix Powerlink System 63 Ribavirin causes 63 Cardiovascular Outcomes 63 tuberous sclerosis TS 63 Bone Metastases 63 ALN HPN 63 Prospective Randomized Trial 63 arteriovenous malformations 63 Total Knee Arthroplasty 63 Autoimmune Diseases 63 pT2 63 Proteinuria 63 pulmonary metastases 63 Adjuvant Treatment 63 Aortic Valve Replacement 63 Restless Legs Syndrome RLS 63 R lenalidomide 63 herpetic keratitis 63 Microplasmin 63 severe mitral regurgitation 63 hypophosphatemia 63 pericardial effusion 63 Renal Function 63 subependymal giant cell 63 severe oral mucositis 63 Methylnaltrexone 63 pulmonary alveolar 63 intravesical instillation 63 Neuropathic 63 FOLOTYN ® 63 peripheral arterial 63 Replacement Therapy 63 psoriatic arthritis PsA 63 ischemic cardiomyopathy 63 cinacalcet 63 Improves Outcomes 63 cystic fibrosis chronic pancreatitis 63 Drug Eluting 63 Endothelial 63 Intra arterial 63 Anti Tumor Activity 63 Rilonacept 63 Multiple Myeloma MM 63 Antitumor Activity 63 esophageal carcinoma 63 morphometric vertebral fractures 63 eosinophilic asthma 63 Inflammatory Markers 63 T2DM 63 biologic DMARD 63 saphenous vein graft 63 SGPT 63 R Saizen R 63 prostate cancer CRPC 63 Subgroup Analysis 63 Exacerbation 63 Resistant Hypertension 63 Overactive Bladder OAB 63 knee osteoarthritis OA 63 Androgen Deprivation Therapy 63 Nonsurgical 63 Hematopoietic 63 Pivotal Phase 63 Irritable Bowel Syndrome IBS 63 Combination Treatment 63 superficial basal cell carcinoma 63 Ozurdex 63 hemodynamic instability 63 Patency 63 diabetic peripheral neuropathy 63 Antifungals 63 aneurysms AAA 63 EECP R 63 relapsing remitting MS RRMS 63 AFREZZA TM 63 Angiographic 63 venous reflux 63 bronchogenic carcinoma 63 Hypercholesterolemia 63 Eisenmenger syndrome 63 venous insufficiency 63 Venous Thrombosis 63 Squamous 63 neurogenic bladder 63 Kidney Transplant Patients 63 GORE TAG Device 63 Patient Outcomes 63 chronic eosinophilic leukemia 63 Unstable Angina 63 ARIXTRA 63 medically inoperable 63 primary immunodeficiency PI 63 AAT deficiency 63 Phase 2a Trial 63 Skeletal Muscle 63 suppurative 63 novel VDA molecule 63 MAGE A3 ASCI 63 Diabetic Nephropathy 62 pediatric malignancies 62 Am Soc Nephrol 62 Interferon Beta 62 peritumoral brain edema 62 Angiotensin Converting Enzyme 62 Myelodysplastic Syndromes 62 miconazole Lauriad ® 62 brand ciclesonide HFA 62 hypercalcaemia 62 Patients Treated 62 chronic periodontitis 62 intravascular hemolysis 62 Demonstrates Positive 62 CIMZIA TM certolizumab pegol 62 GRNCM1 62 Cutaneous 62 Pivotal Phase III 62 Seasonal Allergic Rhinitis 62 hematopoietic cell 62 chemoradiation therapy 62 symptomatic VTE 62 Atopic Dermatitis 62 grade cervical intraepithelial 62 myelodysplastic myeloproliferative diseases 62 catheter occlusion 62 Albuminuria 62 Aliskiren 62 SYN# 62 Diabetic nephropathy 62 Contrast Enhanced 62 transthyretin amyloidosis 62 Chemoradiation 62 Vascugel ® 62 Carotid Stenting 62 disease GERD 62 transplantation HSCT 62 Nonalcoholic Fatty Liver Disease 62 Idiopathic Pulmonary Fibrosis 62 Minimally Invasive Treatment 62 Etanercept 62 Interferon Gamma 62 Fluorouracil 62 Anthracycline 62 By JENNIFER LEARN 62 transarterial 62 Completes Patient Enrollment 62 repair TEVAR 62 transurethral 62 Teriparatide 62 Psoriatic arthritis 62 chronic renal disease 62 Lung Cancer Trial 62 Bronchial Thermoplasty 62 rFVIIa 62 FOLFOX6 62 Fondaparinux 62 mediastinitis 62 Hemophilia B 62 Chronic Lymphocytic Leukemia 62 Cachexia 62 vWF 62 haematologic malignancies 62 Gastroesophageal Reflux Disease 62 ANCA associated 62 GW# [003] 62 Immunotherapeutic 62 haematologic 62 Major Depressive Disorder 62 pioglitazone HCl 62 Disease Progression 62 randomized multicenter trial 62 Chemotherapy induced 62 Peripheral Vascular Disease 62 Lymphocytic 62 abacavir Ziagen 62 Bucindolol 62 mu opioid receptor antagonist 62 gadolinium enhanced 62 Ankylosing Spondylitis 62 Restenosis 62 chronic idiopathic thrombocytopenic purpura 62 renal tumors 62 Randomized Phase 62 mycophenolate mofetil 62 non alcoholic steatohepatitis 62 Multicenter Trial 62 Stenosis 62 J Am Coll 62 Treatment Outcome 62 essential thrombocythemia ET 62 Femoral 62 Chronic Myelogenous Leukemia 62 glomerular filtration 62 IL# PE#QQR 62 Patient Registry 62 Primary Hypercholesterolemia 62 NMIBC 62 Xerostomia 62 Pulmonary Arterial Hypertension PAH 62 neurogenic orthostatic hypotension 62 Systemic Lupus Erythematosus 62 Mycophenolate Mofetil 62 Mitoxantrone 62 intracerebral hemorrhage ICH 62 ximelagatran 62 Eluting Stent 62 Myelodysplastic syndromes MDS 62 colorectal liver metastases 62 RENAL 62 VAPRISOL 62 IMPACT DCM 62 β blockers 62 Patients Suffering 62 pelvic lymphadenectomy 62 GI motility disorders 62 CTAP# 62 aortic valve stenosis 62 Chronic Fatigue Syndrome CFS 62 retinal vein occlusion 62 Valsartan 62 J Foot Ankle 62 schizophrenia CIAS 62 serum phosphorous 62 BCG refractory carcinoma 62 acute peripheral arterial 62 ACTEMRA TM 62 Balloon Catheters 62 LUMINATE 62 CP CPPS 62 Gastric Cancer 62 SIR Spheres 62 Decompensated Heart Failure 62 Peripheral Blood 62 vasculopathy 62 lexidronam injection 62 alpha1 antitrypsin deficiency 62 First Patient Dosed 62 Pediatric Patients 62 Allograft 62 Prostate AdenoCarcinoma Treatment 62 Chronic Hepatitis B 62 Improve Survival 62 metastatic colorectal 62 Glioblastoma Multiforme 62 variceal bleeding 62 Diabetic Ulcers 62 Anti Bacterial Envelope 62 prostate carcinoma 62 VIIBRYD 62 Portal Hypertension 62 percutaneous transluminal coronary angioplasty 62 Peritoneal 62 Hepatitis C Genotype 62 CellCept mycophenolate mofetil 62 Aplidin R 62 Endometrial Cancer 62 unresectable tumors 62 Placebo Controlled Trial 62 Percutaneous vertebroplasty 62 transurethral resection 62 hepatocellular carcinomas 62 TTR amyloidosis 62 Accelerated Partial Breast Irradiation 62 malignant pleural effusion 62 erosive gastritis 62 Endovascular Treatment 62 urothelial cancer 62 TRAIL R1 62 acute coronary syndromes ACS 62 post surgical adhesions 62 metaplasia 62 Enhanced External Counterpulsation 62 Gastric Ulcers 62 transcranial Doppler 62 giant cell arteritis 62 QuadraSphere 62 Risk Stratification 62 paragangliomas 62 Pegylated Interferon 62 Alequel 62 fluvastatin 62 TNF Tumor Necrosis Factor 62 Clinical Trial Evaluating 62 Double Blind Randomized 62 Renal Impairment 62 essential thrombocythemia 62 idiopathic pulmonary fibrosis IPF 62 Bacterial Vaginosis 62 Clostridium difficile Infection 62 Peripheral artery disease 62 Myocet 62 Peptic Ulcer 62 Lubiprostone 62 Sipuleucel T 62 Investigational Treatment 62 atherosclerotic renal artery stenosis 62 Nesiritide 62 Acute Myeloid Leukaemia AML 62 hemorrhagic cerebrovascular events 62 Navelbine 62 Hypertriglyceridemia 62 Stress Incontinence 62 Aortic Valve 62 Preclinical Models 62 choroidal neovascularization CNV 62 ara C 62 adenomatous 62 Percutaneous Transluminal Coronary Angioplasty 62 induced macular edema 62 Nephrol Dial Transplant 62 Contrast Agent 62 Preclinical Study 62 Prophylactic Treatment 62 hypercholesterolaemia 62 Papillary 62 Successfully Treated 62 Community Acquired Pneumonia 62 debilitating complication 62 Randomized Controlled Trials 62 Peginterferon 62 clazosentan 62 Bone Mineral Density 62 acne vulgaris 62 Efficacy Trial 62 opioid induced bowel dysfunction 62 Balloon Kyphoplasty 62 Malignancies 62 allogeneic transplants 62 Radiofrequency Ablation RFA 62 Cardiac Troponin 62 Heart Transplant Recipients 62 radiofrequency RF ablation 62 Shows Promise Against 62 Adefovir 62 Hypoactive Sexual Desire Disorder 62 Erosive 62 brivaracetam 62 abdominal adiposity 62 CLINICAL PHARMACOLOGY 62 acetonide FA 62 Zorbtive TM 62 PEGylated anti 62 Resection 62 samarium Sm 62 C1 INH deficiency 62 Mouse Model 62 acute humoral rejection 62 Platinol ® 62 refractory angina 62 6R BH4 62 Vaprisol 62 Granulocyte Colony Stimulating Factor 62 constipation OIC 62 follicular lymphomas 62 Newly Diagnosed Multiple Myeloma 62 chronic venous insufficiency 62 Golimumab 62 myeloproliferative disorders 62 Acute Heart Failure 62 primary Restless Legs 62 erlotinib Tarceva ® 62 extra articular 62 Syncria R 62 Bare Metal Stent 62 Malignant Glioma 62 chronic rhinosinusitis CRS 62 Chemokine Receptor 62 pouchitis 62 underwent resection 62 Aflibercept 62 Betaferon R 62 Wound Dressing 62 palifermin 62 intravitreal injections 62 diabetic macular edema DME 62 Aortic Dissection 62 esophageal varices 61 Randomized Double blind 61 artery stenting 61 Multicenter Randomized 61 J Clin 61 Orthostatic Hypotension 61 candesartan cilexetil 61 nimodipine 61 LV dysfunction 61 Mantle Cell Lymphoma 61 carotid artery stenting 61 Ranibizumab 61 GORE VIABAHN Endoprosthesis 61 candidemia 61 Cardiopulmonary bypass 61 saphenous vein grafts 61 Phase IIa Clinical Trial 61 dilated cardiomyopathy DCM 61 diabetes mellitus T2DM 61 Inhalation Solution 61 basal cell carcinoma BCC 61 Slow Progression 61 HQK 61 Vascular Grafts 61 chronic myeloid 61 teriflunomide 61 Cardiac Resynchronization 61 hyperhomocysteinemia 61 cutaneous squamous cell carcinoma 61 Basal Cell 61 KETEK 61 Ozarelix 61 tigecycline 61 unstable angina pectoris 61 Periodontitis 61 Epratuzumab 61 BENICAR HCT 61 Lipid Levels 61 refractory prostate cancer 61 Host Disease 61 Ibritumomab Tiuxetan 61 Bosentan 61 renal artery stenting 61 induce orthostatic hypotension 61 headache abdominal pain 61 Crit Rev 61 Artery Disease 61 SPRYCEL ® 61 Glioma 61 Tocilizumab 61 Adjuvant Therapy 61 sitaxsentan 61 cell lymphoma CTCL 61 Kidney Function 61 esophagogastric 61 gastro esophageal reflux 61 Valve Replacement 61 inflammatory acne vulgaris 61 SSc 61 C1 Inhibitor 61 Retinopathy 61 Valvular 61 Anti Inflammatory Drugs 61 IV Busulfex 61 progressive dyspnea 61 Improved Survival 61 Plaque Psoriasis 61 Treated Patients 61 glucocorticoid therapy 61 Lenocta 61 Tacrolimus 61 Visceral Fat 61 Renal Anemia 61 Score TOS 61 lumbar spinal stenosis 61 cancer cachexia 61 Cimzia ® certolizumab pegol 61 Stress Urinary Incontinence 61 either acutely decompensated 61 Levels Linked 61 hemodialysis patients 61 Hematological 61 gastrointestinal GI motility disorders 61 keloid scarring 61 immune thrombocytopenic purpura ITP 61 Enzastaurin 61 Arteriovenous 61 Chronic Renal Failure 61 IIIb 61 Bronchoscopy 61 NB S# strontium malonate 61 J Cataract Refract 61 reflux disease GERD 61 proliferative diabetic retinopathy 61 elevated triglyceride levels 61 Aprotinin 61 polyarticular 61 Relapsed Multiple Myeloma 61 Ablation 61 cTnI 61 fibrin deposition 61 milrinone 61 descending thoracic 61 primidone 61 postoperative morbidity 61 Shows Efficacy 61 Phase 2b Study 61 Laryngeal Cancer 61 Squalamine 61 phase IIb study 61 atherothrombotic 61 Systemic lupus erythematosus 61 metastatic malignant melanoma 61 HoFH 61 Chronic Pelvic Pain 61 Immunoassays 61 recombinant tissue plasminogen 61 Biliary 61 erythematosus 61 Ventricular Arrhythmias 61 generalized epilepsy 61 Ileus 61 Major Depressive Disorder MDD 61 Spasticity 61 hyperplastic 61 treating abdominal aortic 61 Liver Injury 61 pericardial effusions 61 pediatric Crohn disease 61 Prostatic 61 SNT MC# 61 epithelial ovarian 61 Chronic Wounds 61 Inflammatory Bowel Diseases 61 Tumor Necrosis Factor 61 Endothelial dysfunction 61 Traficet EN 61 Delayed Graft Function 61 CCX# B 61 Myoblast 61 dose cytarabine 61 pyridostigmine 61 Recombinant Human 61 MGd 61 mg BID dose 61 noninfectious uveitis 61 acute PAO 61 F FDG PET 61 polycythemia vera PV 61 RAPAFLO R 61 Atherosclerotic 61 colorectal adenoma 61 First Patient Treated 61 lomitapide 61 Growth Hormone Deficiency 61 Sjögren syndrome 61 Secca System 61 standard chemotherapy regimen 61 Acute Exacerbations 61 ritonavir boosted 61 Obstructive Sleep Apnea 61 Graft versus 61 Bivalirudin 61 NOMID 61 varices 61 superficial basal cell carcinomas